Elitek

Active Ingredient(s): Rasburicase
FDA Approved: * July 12, 2002
Pharm Company: * SANOFI SYNTHELABO
Category: Cancer

Rasburicase (trade names Elitek in the US and Fasturtec in the EU) is a medication that helps to clear uric acid from the blood. It is a recombinant version of urate oxidase, an enzyme that metabolizes uric acid to allantoin. Urate oxidase is known to be present in many mammals but does not naturally occur in humans.[1] Rasburicase is produced by a genetically modified Saccharomyces cerevisiae strain. The complementary DNA (cDNA) coding for rasburicase was cloned from a strain... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Elitek Kit
NDC: 0024-5150
Labeler:
Sanofi-aventis U.S. LLC
Elitek Kit
NDC: 0024-5151
Labeler:
Sanofi-aventis U.S. LLC

Related Brands

Drugs with the same active ingredients